News Reports
Top News Stories
Emory Clinic Vascular Surgery Wins 3 Star SVS-VQI Award
April 2019
The Society for Vascular Surgery's Vascular Quality Initiative (SVS-VQI) has announced its 2018 VQI Participation Awards, which included a 3 Star Certificate for the Emory Clinic Vascular Surgery Service. This represents the highest level of recognition for active participants in the VQI and its mission to increase the quality, safety, and effectiveness of vascular health care while lowering costs. Out of the 383 vascular surgery centers eligible for the Participation Awards, the Emory Clinic was one of 44 given the 3 Star award.
Emory Surgery's Top Providers in Q2 of 2019
April 2019
Emory Healthcare's Patient Experience team has announced the Top Providers for the second quarter of FY2019, according to Press Ganey patient survey scores. The following Emory Surgery faculty were included: Felix Fernandez, Robert Guyton, Michael Halkos (CT Surgery), Glenn Balch (Colorectal Surgery), Edward Lin, Neil Saunders, Joe Sharma (General & GI Surgery), Stephanie Drew (Oral & Maxillofacial Surgery), Felmont Eaves III, Gabriele Miotto (Plastic & Reconstructive Surgery), Cletus Arciero, David Kooby, Shishir Maithel (Surgical Oncology), Olamide Alabi, and Michael Clark (Vascular Surgery).
Mandy Ford Honored With 2019 AST Basic Science Investigator Award
March 2019
Mandy Ford, PhD, scientific director of the Emory Transplant Center, has been designated as this year's recipient of the Basic Science Investigator Award of the American Society of Transplantation. This prestigious award is given by the AST to recognize investigators who have made substantial contributions to the field of transplantation medicine and show great promise for continuing to make such contributions in the future.
Lily Yang and Colleagues Test New Nanoparticle as Therapy for Advanced Melanoma
March 2019
As co-investigator, Lily Yang, MD, PhD, Nancy Panoz Chair of Surgery in Cancer Research, collaborated with principal investigator Jack Arbiser, MD, PhD, Thomas J. Lawley Professor of Dermatology, and colleagues on the design of chemotherapeutic nanoparticles that would target the IGF1R and CD44 protein receptors that are crucial for tumor growth and excessively expressed in most advanced melanomas. The process and conclusions of this study were published in Scientific Reports.
Emory Surgery Places 7th in 2018 NIH Funding Rankings
February 2019
In FY2017, the Emory Department of Surgery rose from the 9th position it held for the prior two years in funding from the NIH for all departments of surgery nationwide to reach the 7th. According to ranking tables of annual NIH funding for FY2018 recently posted by the Blue Ridge Institute for Medical Research, we have retained the 7th position as well as received an increase in funding of more than $2 million.